17 insiders reported 824 Form 4 transactions for Natera, Inc. (NTRA) over the past 18 months (most recent 2026-07-06). Recent activity: RABINOWITZ DANIEL (SEC. AND CHIEF LEGAL OFFICER) Sell 2,045 shares, RABINOWITZ DANIEL (SEC. AND CHIEF LEGAL OFFICER) Sell 300 shares, RABINOWITZ DANIEL (SEC. AND CHIEF LEGAL OFFICER) Sell 3,705 shares, Moshkevich Solomon (PRESIDENT, CLINICALDIAGNOSTICS) Sell 2,600 shares, RABINOWITZ DANIEL (SEC. AND CHIEF LEGAL OFFICER) Sell 1,932 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 2,045 | $567,056 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 300 | $83,630 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 3,705 | $993,330 |
| 2026-07-06 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 2,600 | $709,774 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,932 | $519,694 |
| 2026-07-06 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 300 | $82,218 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 484 | $130,616 |
| 2026-07-06 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sell | 100 | $26,718 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 454 | $123,551 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 500 | $137,095 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,100 | $302,717 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,400 | $386,740 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,568 | $418,331 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,955 | $543,973 |
| 2026-07-06 | RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER | Sell | 1,357 | $367,699 |
| 2026-06-30 | Rubin Eric H | Director | Buy | 75 | $0 |
| 2026-06-30 | Chapman Rowan E | Director | Buy | 1,571 | $0 |
| 2026-06-30 | Bertagnolli Monica | Director | Buy | 1,571 | $0 |
| 2026-06-30 | Marcus Gail Boxer | Director | Buy | 1,571 | $0 |
| 2026-06-30 | Bertagnolli Monica | Director | Buy | 75 | $0 |
| 2026-06-30 | Lynch Thomas J. Jr. | Director | Buy | 1,905 | $0 |
| 2026-06-30 | ROSENMAN HERM | Director | Buy | 1,571 | $0 |
| 2026-06-30 | BOTHA ROELOF | Director | Buy | 1,571 | $0 |
| 2026-06-30 | Chapman Rowan E | Director | Buy | 103 | $0 |
| 2026-06-30 | Baynes Roy D. | Director | Buy | 1,571 | $0 |
Source: SEC Form 4 filings · as of 2026-07-06